James River Group Holdings Inc. Common Stock (JRVR)
TurnaroundFairStock Score: 85/100 — HIGH CONVICTION
Key Financials
| Current Price | $3.97 |
| Market Cap | $184M |
| P/E Ratio | 9.02 |
| ROE | 4.93% |
| Dividend Yield | 1.09% |
| Sector | Financial Services |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
As a value investor, I start with the price and the record. At the 2026-10-13 close of $3.71, FairStock calculates a market cap of $171.5M, a P/E of 8.43, and a P/B of 0.33. That is a cigar-butt-looking valuation: the market is saying the book value may not be trustworthy. The Lynch category is Turnaround, because James River returned to profit after losses within the last three years. Filed figures show the scale of that swing: net income was -$107.7M in fiscal year 2023, -$81.1M in fiscal year 2024, then $47.4M in fiscal year 2025. In the latest filed quarter, fiscal Q2 2026 (the quarter ended 2026-06-30), revenue was $161.3M, net income $6.4M, and diluted EPS $0.10. But fiscal Q1 2026 (the quarter ended 2026-03-31) still lost $8.9M, or $0.23 per diluted share, so consistency is not there. Business quality is mixed. Specialty excess-and-surplus insurance can be a decent niche, but I see no durable moat in the data. FairStock's ROE is only 4.93% and ROCE 0.62%, while the latest quarter's net margin was 3.97%—thin for an insurer. D/E of 0.50 is not alarming, and a negative beta of -0.21 may add diversification, but insurance is a leverage business where reserve mistakes can erase years of profit. The data do not include a combined ratio, CET1, or NIM, so I cannot fully assess underwriting or capital adequacy. Revenue has also slipped from $812.0M in fiscal year 2023 to $687.6M in fiscal year 2025. The Piotroski F-Score is 4/9. At 0.33 times book, the stock is cheap if the recovery holds; if reserve or underwriting problems return, it is a value trap.
In plain English: James River sells specialty insurance to businesses. It lost money in 2023 and 2024 but made a profit in 2025 and again in the latest quarter, so it looks like an early turnaround. The price looks cheap against its assets and profits, but insurance results have been uneven and the business still carries risk.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash
Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)
Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer